PGR and breast carcinoma: Among the breast cancer cell line, triple-negative 4T1 murine breast cancer cells have been widely used as an in vitro and in vivo model for drug discovery against TNBC as it is highly tumorigenic, metastatic, and does not express ER, PR, and HER2 receptors [5].